PVP Ventures Acquires Rs 1.27 Billion Stake in 7Med

29 Aug 2025 CW Team

The transaction, valued at Rs 1.27 billion, involves a mix of primary and secondary stake purchases. This investment aligns with PVP's ambition to build a new-age global healthcare services platform focused on illness, wellness, and care.

Founded by leading nephrology and urology specialists, 7Med operates 22 dialysis centres—both standalone and within hospitals—across six Indian states. It also runs four super-speciality hospitals with a focus on renal care. The company, headquartered in Delhi NCR, employs over 450 professionals and has conducted over one million dialysis procedures to date.

7Med reported an EBITDA of approximately Rs 100 million for FY25, and with PVP’s infusion, aims to scale this to Rs 500 million over the next four years. Expansion plans include broadening its presence in Tier 2 and Tier 3 cities and significantly upgrading local healthcare infrastructure.

Mr Gaurav Davda, Head of M&A and Strategy at PVP, emphasised that the acquisition marks a pivotal step in creating a trusted healthcare brand network tailored to emerging markets. Dr Vijay Kher, Chairman of Epitome Hospitals, added that the partnership would enhance operational efficiency and accelerate access to quality kidney care across geographies.

PVP Ventures, traditionally rooted in real estate, is now actively diversifying through acquisitions. It has partnered with Brigade Enterprises and Casagrand to monetise legacy real estate assets, expecting over Rs 20 billion in cash flows over the next six years, which will be channelled into its healthcare ambitions.

With this deal, PVP Ventures positions itself as a major player in India’s healthcare transformation, targeting both impact and scale in a rapidly growing sector.

PVP Ventures Limited has announced the acquisition of a significant stake in 7Med India Pvt Ltd and Epitome Group of Hospitals, marking a strategic expansion into the healthcare sector. The Board has approved the purchase of an initial 41.2 per cent stake, with a clear roadmap to majority ownership within 12 months and an eventual increase to 76 per cent.The transaction, valued at Rs 1.27 billion, involves a mix of primary and secondary stake purchases. This investment aligns with PVP's ambition to build a new-age global healthcare services platform focused on illness, wellness, and care.Founded by leading nephrology and urology specialists, 7Med operates 22 dialysis centres—both standalone and within hospitals—across six Indian states. It also runs four super-speciality hospitals with a focus on renal care. The company, headquartered in Delhi NCR, employs over 450 professionals and has conducted over one million dialysis procedures to date.7Med reported an EBITDA of approximately Rs 100 million for FY25, and with PVP’s infusion, aims to scale this to Rs 500 million over the next four years. Expansion plans include broadening its presence in Tier 2 and Tier 3 cities and significantly upgrading local healthcare infrastructure.Mr Gaurav Davda, Head of M&A and Strategy at PVP, emphasised that the acquisition marks a pivotal step in creating a trusted healthcare brand network tailored to emerging markets. Dr Vijay Kher, Chairman of Epitome Hospitals, added that the partnership would enhance operational efficiency and accelerate access to quality kidney care across geographies.PVP Ventures, traditionally rooted in real estate, is now actively diversifying through acquisitions. It has partnered with Brigade Enterprises and Casagrand to monetise legacy real estate assets, expecting over Rs 20 billion in cash flows over the next six years, which will be channelled into its healthcare ambitions.With this deal, PVP Ventures positions itself as a major player in India’s healthcare transformation, targeting both impact and scale in a rapidly growing sector.

Resources

09 Mar 2026

Haworth India Hosts Women’s Leadership Panel Series

Haworth India marked International Women’s Day by hosting a leadership roundtable series titled ‘Give to Gain’, bringing together senior women leaders from architecture and design firms, corporates and project management consultancies. The series has been conducted in Delhi and Mumbai, with upcoming sessions scheduled in Bengaluru and Hyderabad on 27 March 2026. Structured as moderated panel discussions followed by audience interaction, the initiative examined the business impact of women’s leadership and the role of inclusive workplaces in supporting professional growth. Manish Khan..

Real Estate

09 Mar 2026

Max Estates Secures RERA For Max One Project

Max Estates has secured RERA approval (UPRERA No.: UPRERAPRJ9759) for its Max One development around Max Towers in Sector 16B, Noida, bringing renewed progress to a project previously stalled following the insolvency of its earlier developer. Spread across around 10 acres with an estimated development potential of about 2.5 million sq ft, Max One is planned as an integrated mixed-use campus combining serviced residences, premium offices, retail spaces and a private club. The project is expected to generate total sales potential of about Rs 20 billion along with an estimated annuity rental inc..

Real Estate

09 Mar 2026

Hindware Introduces Starc Smart Wall Mount Toilet

Hindware has introduced the Starc Smart Wall-Mount Toilet under its Hindware Italian Collection, designed to combine automation, hygiene and contemporary bathroom aesthetics. The model features automatic flushing, sensor-based seat opening and closing, and remote-controlled functions. It also includes an oscillating water spray and warm air dryer for cleaning, along with a self-cleaning nozzle designed to maintain hygiene. Additional features include adjustable heated seating, customisable water temperature and pressure settings, a foot-touch flush system and an LCD control interface. The wa..